Ozgur Mete Selected Research

Anterior Pituitary Hormones

10/2019	Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.
9/2017	Overview of the 2017 WHO Classification of Pituitary Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ozgur Mete Research Topics

Disease

62	Neoplasms (Cancer) 12/2023 - 12/2012
12	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 10/2013
11	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 08/2012
10	Carcinoma (Carcinomatosis) 03/2022 - 10/2009
9	Paraganglioma (Paragangliomas) 12/2023 - 01/2014
9	Adenoma (Adenomas) 10/2019 - 08/2012
8	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 02/2010
8	Parathyroid Neoplasms (Parathyroid Neoplasm) 03/2022 - 12/2012
6	Adrenocortical Adenoma (Disease, Conn's) 09/2020 - 01/2009
6	Hyperplasia 01/2019 - 01/2013
5	Acromegaly 09/2023 - 08/2012
4	Pheochromocytoma 01/2021 - 01/2014
4	Pituitary ACTH Hypersecretion 01/2021 - 08/2013
4	Papillary Thyroid Cancer 01/2021 - 12/2012
4	Inflammation (Inflammations) 10/2019 - 12/2012
3	Necrosis 03/2023 - 01/2021
3	Hyperaldosteronism (Conn Syndrome) 03/2022 - 07/2015
3	Adrenocortical Carcinoma 01/2021 - 01/2018
3	Hypercalcemia (Milk Alkali Syndrome) 03/2020 - 12/2018
3	Cushing Syndrome 01/2018 - 03/2015
2	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2019
2	Thrombosis (Thrombus) 03/2023 - 03/2022
2	Ganglioneuroma 03/2022 - 01/2019
2	Craniopharyngioma (Craniopharyngiomas) 03/2021 - 01/2018
2	Neuroendocrine Carcinoma 03/2021 - 04/2017
2	Adenocarcinoma 01/2021 - 10/2013
2	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2019 - 04/2017
2	Hyperparathyroidism 12/2018 - 10/2015
2	Lymphatic Metastasis 01/2017 - 09/2016
2	Multiple Endocrine Neoplasia Type 1 02/2016 - 10/2013
2	Disease Progression 01/2016 - 10/2013
1	Hyperthyroidism 09/2023
1	Margins of Excision 03/2023
1	Neuroma 03/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2022

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 03/2022 - 10/2012
17	Hormones (Hormone)IBA 01/2023 - 08/2013
10	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2015
9	Keratins (Keratin)IBA 01/2023 - 10/2013
7	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2023 - 01/2014
7	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023 - 08/2012
7	Proteins (Proteins, Gene)FDA Link 09/2020 - 12/2012
5	GlucocorticoidsIBA 01/2021 - 03/2015
4	AldosteroneIBA 03/2022 - 01/2009
4	CalciumIBA 03/2020 - 01/2018
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 05/2012
3	Capsules (Microcapsules)IBA 11/2023 - 02/2010
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2023 - 03/2016
3	ProlactinIBA 09/2023 - 01/2018
3	Growth Hormone (Somatotropin)IBA 09/2023 - 08/2012
3	CAM 5.2 antigenIBA 01/2023 - 11/2013
3	Chromogranin AIBA 01/2023 - 11/2013
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2023 - 06/2019
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2022 - 01/2013
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2022 - 09/2014
3	CatecholaminesIBA 03/2022 - 09/2014
3	Parathyroid Hormone (Parathormone)IBA 12/2018 - 10/2015
3	CateninsIBA 11/2018 - 07/2015
3	Cyclic AMP (AMP, Cyclic)IBA 01/2018 - 03/2015
3	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 10/2012
2	FibrinIBA 03/2023 - 03/2022
2	SynaptophysinIBA 01/2023 - 03/2022
2	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2023 - 12/2021
2	Glucagon (Glukagon)FDA Link 01/2023 - 12/2021
2	GastrinsIBA 01/2023 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2016
2	inhibin-alpha subunitIBA 03/2022 - 01/2021
2	Reticulin (Reticular Fiber)IBA 03/2022 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2022 - 08/2014
2	IodineIBA 01/2021 - 12/2012
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 03/2010
2	LipidsIBA 01/2021 - 10/2013
2	Monoclonal AntibodiesIBA 03/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2019 - 12/2012
2	Anterior Pituitary HormonesIBA 10/2019 - 09/2017
2	TOR Serine-Threonine KinasesIBA 03/2018 - 12/2012
2	Cyclin D1IBA 10/2015 - 12/2012
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2015 - 03/2015
1	Succinic Acid (Succinate)IBA 12/2023
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2023
1	Follicle Stimulating Hormone (Follitropin)FDA Link 09/2023
1	Peptide YYIBA 01/2023
1	Brachyury protein (Brachyury)IBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2022
1	EnzymesIBA 03/2022
1	Dopamine beta-HydroxylaseIBA 03/2022
1	Levodopa (L Dopa)FDA LinkGeneric 03/2022
1	ChromograninsIBA 03/2022
1	Tyrosine (L-Tyrosine)FDA Link 03/2022
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2022
1	Phenylethanolamine N-MethyltransferaseIBA 03/2022
1	GATA3 Transcription FactorIBA 03/2022

Therapy/Procedure

14	Therapeutics 12/2023 - 12/2012
4	Radiotherapy 01/2021 - 12/2012
3	Adrenalectomy 06/2015 - 01/2009
2	Parathyroidectomy 03/2022 - 10/2015